查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球伴同性動物診斷市場：按產品、按應用、按動物類型、按最終用戶、按技術、按地區 - 預測至 2029 年
市場調查報告書
商品編碼
1630480

全球伴同性動物診斷市場：按產品、按應用、按動物類型、按最終用戶、按技術、按地區 - 預測至 2029 年

Companion Animal Diagnostics Market by Product, Technology, Application, Animal, End User - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 421 Pages | 訂單完成後即時交付

價格

伴同性動物診斷市場規模預計將從 2024 年的 29.9 億美元增至 2029 年的 45.5 億美元，預測期內複合年成長率為 8.8%。

更多用於診斷的動物、有利的立法和動物保險的持續可用性預計將對該市場的持續發展做出重大貢獻。在法規要求獸醫專業知識水平較高的國家，寵物飼主更有可能將他們的動物委託給醫生並定期進行健康檢查。現在，比以往任何時候都有更多的人可以獲得包括診斷在內的寵物保險，從而改善了獲得獸醫護理的機會。保險公司現在能夠提供涵蓋血液檢測、影像和篩檢等診斷服務的計劃，以便及時進行預防性治療。這一趨勢預計將確保寵物的健康，進一步擴大診斷工具和服務市場，並進一步發展和成長整個產業的需求。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2030
考慮單位 金額（美元）
按細分市場 按產品、按應用、按動物類型、按最終用戶、按技術、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東非洲

具有診斷設施的獸醫院和診所的出現大大增加了對診斷耗材的需求。隨著越來越多的獸醫診所配備了先進的診斷設備，對消耗性檢測試劑套件、成像用品和試劑的需求比平時增加了。這也代表了改善寵物醫療保健的主要趨勢，因為寵物飼主不斷尋求更好的獸醫服務以準確診斷所有疾病。提供特定服務的專科診所和醫院數量不斷增加，導致用於常規檢查、疾病檢測和疾病治療監測的耗材的使用量增加。現代診斷設備在獸醫診所的使用不僅提高了診斷的準確性，而且有利於定期檢測，進而增加了對耗材的需求。所有這些原因都顯示獸醫診斷能力的加強是全球診斷產品和服務整體市場持續成長的潛在原因。

狗的品種迅速多樣化，每個品種對不同的健康狀況都有獨特的遺傳傾向，這日益凸顯了對特定品種診斷測試的需求。隨著特定品種護理在狗飼主中變得非常流行，獸醫擴大承擔識別某些狗品種中更常見的疾病的任務。心臟病、髖關節發育不良和某些癌症等疾病需要專門的診斷技術來進行早期發現和有效管理。對檢測這些特定品種現象的診斷工具和測試的需求為準確和個性化的獸醫學鋪平了道路。基因檢測的改進使獸醫能夠進行更準確的篩檢，從而實現早期療育並改善健康結果。隨著該品種變得越來越受歡迎，與這些遺傳標誌相關的專業診斷服務將會激增，這肯定會進一步影響獸醫診斷市場。

該報告研究了全球伴同性動物診斷市場，包括按產品、應用、動物類型、最終用戶、技術、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 疾病趨勢
  • 技術分析
  • 貿易分析
  • 價格分析
  • 影響客戶業務的趨勢/干擾
  • 價值鏈分析
  • 生態系分析
  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 專利分析
  • 2024-2025年重大會議和活動
  • 主要相關人員和採購標準
  • 案例研究分析
  • 鄰近市場分析
  • 伴同性動物診斷市場中未滿足的需求/最終用戶期望
  • 人工智慧/產生人工智慧對伴同性動物診斷市場的影響
  • 投資金籌措場景

第6章伴同性動物診斷市場，分產品

  • 介紹
  • 消耗品
  • 裝置

第7章伴同性動物診斷市場（按應用）

  • 介紹
  • 臨床病理學
  • 細菌學
  • 病毒學
  • 寄生蟲學
  • 其他

第8章伴同性動物診斷市場（依動物類型）

  • 介紹
  • 狗
  • 貓
  • 馬
  • 其他

第9章伴同性動物診斷市場（依最終用戶）

  • 介紹
  • 診斷實驗室
  • 獸醫院/診所
  • 動物醫學研究所和大學
  • 居家醫療

第10章伴同性動物診斷市場（依技術）

  • 介紹
  • 臨床生物化學
  • 免疫診斷
  • 血液學
  • 尿液檢查
  • 分子診斷
  • 其他

第11章伴同性動物診斷市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 比荷盧經濟聯盟
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東/非洲
    • 不願在寵物健康上花錢限制了市場
    • 中東和非洲宏觀經濟前景
  • 海灣合作理事會國家
    • 進口品種感染疾病率上升支持市場成長
    • 海灣合作理事會國家的宏觀經濟前景

第12章競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 公司評價及財務指標
  • 品牌/產品比較
  • 伴同性動物診斷公司的研發費用
  • 競爭場景

第13章 公司簡介

  • 主要參與企業
    • IDEXX
    • ZOETIS SERVICES LLC
    • MARS, INCORPORATED
    • BIOMERIEUX
    • FUJIFILM CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • NEOGEN CORPORATION
    • VIRBAC
    • BOULE
    • INDICAL BIOSCIENCE GMBH
    • IDVET
    • RANDOX LABORATORIES, LTD.
    • SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
    • BIONOTE USA INC.
    • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • 其他公司
    • SKYLA CORPORATION
    • EUROLYSER DIAGNOSTICA GMBH
    • NOVA BIOMEDICAL
    • FASSISI GMBH
    • SWISS BIOTECH ASSOCIATION
    • ALVEDIA
    • BIOPANDA REAGENTS LTD.
    • MEGACOR VETERINARY DIAGNOSTICS
    • URIT MEDICAL ELECTRONIC CO., LTD.
    • RING BIOTECHNOLOGY CO., LTD.

第14章附錄

Product Code: MD 7053

The companion animal diagnostics market is projected to reach USD 4.55 Billion by 2029 from USD 2.99 Billion in 2024 at a CAGR of 8.8% during the forecast period. Favorable laws and ever-present availability of animal insurance, with more animals getting diagnostics-covered, would greatly contribute to the continued development of this market. In countries implementing regulation that forces a higher degree of veterinary expertise, pet owners tend to entrust their animals with doctors and get health check-up diagnostics done periodically. With pet insurance that includes diagnostics availability to a greater percentage of the population than before, due to this access to veterinary care is increased. Insurance companies can now offer plans that can cover diagnostic services like blood tests, imaging, and screenings in order to make it worthwhile to seek timely and preventive care. This trend will ensure healthy pets and further the diagnostic tools and services markets, through which it will provide for further development and growth in demand all over the sector.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsBy Product, Technology, Animal Type, Application, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East Africa.

"The consumables segment is accounted for the largest share of companion animal diagnostics market."

The global emergence of veterinary clinics and hospitals with diagnostic facilities has significantly enhanced the demand for consumables used in diagnostics. This has more-than-normal increased the demand for consumables test kits, imaging supplies, and reagents as more veterinary practices are equipped with advanced diagnostics. Superlatively, it is also indicative of a larger trend toward improving healthcare for pets, as pet owners continue to seek better veterinary services for accurate diagnosis of all diseases. On-the-rise number of specialized clinics and hospital businesses offering specific services adds to the use of consumables utilized for routine checkups, disease detection, and disease treatment monitoring. Availability of the most modern diagnostic equipment in veterinary settings not only improves accurate diagnosis, but also promotes regular testings which in turn puts a higher demand on consumables. All these reasons illustrate the strengthening of diagnostic capabilities in veterinary medicine as a potential reason for the continued growth of the overall global market for diagnostic products and services.

"Dogs holds the largest market share of companion animal diagnostics market."

The rapidly increasing diversity of dog breeds, each having unique genetic predispositions for different health conditions, is increasingly accentuating the need for breed-specific diagnostic tests. With breed-specific care becoming extremely popular among dog owners, so also have the avocations of veterinarians in spotting conditions that are more prevalent in certain breeds. These are a few diseases, including heart disease, hip dysplasia, and certain types of cancers, under which the patient is required to undergo specialized diagnostic techniques for early detection and effective management. Demand for such diagnostic tools and tests to detect these breed-specific phenomena has thereby opened the way for precise and personalized veterinary care. Now possible with improvements in genetic testing, veterinarians can provide more accurate screenings for early intervention and better health outcomes. As dog breeds become more popular, there is bound to be an upsurge for specialty diagnostic service relative to these genetic signs that will further impact the veterinary diagnostics markets.

"North America to witness the substantial growth rate during the forecast period."

The companion animal diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2023, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the companion animal diagnostics market in 2023. Due to increasing incidences of pet health issues such as cancer, diabetes, and kidney diseases, the demand for newer and advanced diagnostic tests will rise to detect and treat these diseases. Most of the pet owners in North America are now seeking quick and reliable diagnostics for better health outcomes for their pets. Some of the larger veterinary infrastructure and rising public interest in pet health have also spurred the use of these "diagnostic tools and technologies." The availability of ready pet insurance that covers most of the diagnostic services has also increased access to quality care for pet owners. Thus, because the number of pets suffering from chronic and infectious diseases keeps climbing, market demand for companion animal diagnostics will only continue to grow, further bolstering North America's superiority in the global market.

A breakdown of the primary participants (supply-side) for the companion animal diagnostics market referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-30%, and Tier 3-25%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America- 10%, and Middle East and Africa- 3% and GCC Countries- 2%

Prominent players in this market include IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMerieux (France), Thermo Fisher Scientific Inc (US), Virbac (France), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH (Germany), IDvet (France), Randox Laboratories Ltd. (UK), Shenzhen Mindray Animal Medical Technology Co., LTD. (China), Bionote USA Inc. (US), Boule (Sweden), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Biopanda Reagents Ltd (UK), Nova Biomedical (US), Megacor Veterinary Diagnostics (Austria), Eurolyser Diagnostica GmbH (Austria), URIT MEDICAL ELECTRONIC CO., LTD. (China), Fassisi GmbH (Germany), Swissavans AG (Switzerland), Skyla Corporation (Taiwan), Ring Biotechnology Co Ltd (China), and Alvedia (France).

Research Coverage:

The market study covers the companion animal diagnostics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, technology, animal type, application, end user and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of Market Dynamics: Drivers (expansion in companion animal population, increasing demand for pet insurance and growing animal health expenditure, growing number of veterinary practitioners) restraints (rising pet care costs) opportunities (growing demand for rapid tests and portable instruments for POC diagnostics, utilization of AI and ML for enhanced disease diagnosis), and challenges (shortage of veterinary practitioners in emerging markets)
  • Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the companion animal diagnostics market.
  • Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the companion animal diagnostics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the companion animal diagnostics market like IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMerieux (France).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW
  • 4.2 COMPANION ANIMAL DIAGNOSTICS MARKET: REGIONAL MIX
  • 4.3 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY & COUNTRY (2023)
  • 4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Expansion in companion animal population
      • 5.2.1.2 Increasing demand for pet insurance and growth in animal healthcare expenditure
      • 5.2.1.3 Growing number of veterinary practitioners
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Rising pet care costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for rapid tests and portable instruments for POC diagnostics
      • 5.2.3.2 Utilization of AI and ML for enhanced disease diagnosis
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of veterinary practitioners in emerging markets
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADOPTION OF MULTIPLE TESTING PANELS
    • 5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
  • 5.4 DISEASE TRENDS
    • 5.4.1 ZOONOTIC DISEASES
    • 5.4.2 OBESITY & DIABETES
  • 5.5 TECHNOLOGICAL ANALYSIS
    • 5.5.1 KEY TECHNOLOGIES
      • 5.5.1.1 Portable instruments
    • 5.5.2 COMPLEMENTARY TECHNOLOGIES
      • 5.5.2.1 Wearable health monitoring devices
    • 5.5.3 ADJACENT TECHNOLOGIES
      • 5.5.3.1 Rapid vet diagnostic kits
  • 5.6 TRADE ANALYSIS
    • 5.6.1 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS (HS CODE 9018)
    • 5.6.2 EXPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018)
    • 5.6.3 IMPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018)
  • 5.7 PRICING ANALYSIS
    • 5.7.1 AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTICS, BY KEY PLAYER (2023)
    • 5.7.2 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION (2021-2023)
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 VALUE CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • 5.11.1 THREAT OF NEW ENTRANTS
    • 5.11.2 THREAT OF SUBSTITUTES
    • 5.11.3 BARGAINING POWER OF SUPPLIERS
    • 5.11.4 BARGAINING POWER OF BUYERS
    • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 SUPPLY CHAIN ANALYSIS
  • 5.13 REGULATORY ANALYSIS
    • 5.13.1 REGULATORY LANDSCAPE
      • 5.13.1.1 North America
      • 5.13.1.2 Europe
      • 5.13.1.3 Asia Pacific
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PATENT ANALYSIS
    • 5.14.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS
    • 5.14.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.15 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.16.2 BUYING CRITERIA
  • 5.17 CASE STUDY ANALYSIS
    • 5.17.1 CASE STUDY 1: OPPORTUNITY ASSESSMENT FOR AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS
    • 5.17.2 CASE STUDY 2: IDENTIFICATION OF INTESTINAL PARASITES IN PET DOGS
    • 5.17.3 CASE STUDY 3: INTRODUCTION OF PETLY PLANS BY IDEXX FOR HIGHER VOLUME OF PATIENT VISITS
  • 5.18 ADJACENT MARKET ANALYSIS
    • 5.18.1 VETERINARY DIAGNOSTICS MARKET
    • 5.18.2 VETERINARY REFERENCE LABORATORY MARKET
  • 5.19 UNMET NEEDS/END-USER EXPECTATIONS IN COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.20 IMPACT OF AI/GEN AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.21 INVESTMENT & FUNDING SCENARIO

6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 GROWING AWARENESS OF PREVENTIVE CARE TO DRIVE MARKET
  • 6.3 INSTRUMENTS
    • 6.3.1 ADOPTION OF RAPID TESTS FOR INFECTIOUS DISEASE DIAGNOSTICS TO PROPEL MARKET

7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL PATHOLOGY
    • 7.2.1 INCREASING VOLUME OF CLINICAL TESTS FOR DISEASE DIAGNOSIS TO DRIVE MARKET
  • 7.3 BACTERIOLOGY
    • 7.3.1 INCREASING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET
  • 7.4 VIROLOGY
    • 7.4.1 INCREASING INCIDENCE OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH
  • 7.5 PARASITOLOGY
    • 7.5.1 RISING PREVALENCE OF KENNEL COUGH AND LYME DISEASE TO FUEL UPTAKE
  • 7.6 OTHER APPLICATIONS

8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 DOGS
    • 8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET
  • 8.3 CATS
    • 8.3.1 GROWING FOCUS ON R&D FOR FELINE CARE TO FUEL UPTAKE
  • 8.4 HORSES
    • 8.4.1 INCREASING AWARENESS OF EQUINE HEALTH TO SUPPORT MARKET GROWTH
  • 8.5 OTHER COMPANION ANIMALS

9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASING VOLUME OF SAMPLE TESTS TO DRIVE MARKET
  • 9.3 VETERINARY HOSPITALS & CLINICS
    • 9.3.1 RISING PET CARE EXPENDITURE TO FUEL MARKET
  • 9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
    • 9.4.1 FAVORABLE INDUSTRY-ACADEMIA COLLABORATIONS TO SUPPORT MARKET GROWTH
  • 9.5 HOME CARE SETTINGS
    • 9.5.1 IMPROVED CARE AND COST EFFICIENCY TO PROPEL MARKET

10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 10.1 INTRODUCTION
  • 10.2 CLINICAL BIOCHEMISTRY
    • 10.2.1 CLINICAL CHEMISTRY ANALYSIS
      • 10.2.1.1 Reagents, clips, and cartridges
        • 10.2.1.1.1 Ability to customize chemistry diagnostic tests to fuel uptake
      • 10.2.1.2 Analyzers
        • 10.2.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth
    • 10.2.2 GLUCOSE MONITORING
      • 10.2.2.1 Blood glucose strips
        • 10.2.2.1.1 Growing focus on remote monitoring to drive market
      • 10.2.2.2 Glucose monitors
        • 10.2.2.2.1 Utilization of portable BGMs to drive market
      • 10.2.2.3 Urine glucose strips
        • 10.2.2.3.1 Measurement of ketone concentration to drive market
    • 10.2.3 BLOOD GAS ELECTROLYTE ANALYSIS
      • 10.2.3.1 Reagents, clips, and cartridges
        • 10.2.3.1.1 Detection of blood pH to fuel uptake
      • 10.2.3.2 Blood gas & electrolyte analyzers
        • 10.2.3.2.1 Determination of oxygen and CO2 in blood to boost demand
  • 10.3 IMMUNODIAGNOSTICS
    • 10.3.1 LATERAL FLOW ASSAYS
      • 10.3.1.1 Rapid tests
        • 10.3.1.1.1 Increasing prevalence of infectious diseases and real-time monitoring to drive market
      • 10.3.1.2 Strip readers
        • 10.3.1.2.1 High adoption of in-house testing centers to fuel uptake
    • 10.3.2 ELISA TESTS
      • 10.3.2.1 High sensitivity to fuel uptake
    • 10.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
      • 10.3.3.1 Increasing number of allergy cases in pets to support market growth
    • 10.3.4 IMMUNOASSAY ANALYZERS
      • 10.3.4.1 Ability to handle large number of samples for immunoassay testing to boost demand
    • 10.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
  • 10.4 HEMATOLOGY
    • 10.4.1 CARTRIDGES
      • 10.4.1.1 Ability to measure hematocrit and hemoglobin levels in blood samples to drive market
    • 10.4.2 ANALYZERS
      • 10.4.2.1 Complete blood analysis performance evaluation to boost demand
  • 10.5 URINALYSIS
    • 10.5.1 CLIPS & CARTRIDGES
      • 10.5.1.1 Detection of UTIs in cats, dogs, and equine to boost demand
    • 10.5.2 URINE ANALYZERS
      • 10.5.2.1 Rising technological advancements to support market growth
    • 10.5.3 URINE TEST STRIPS
      • 10.5.3.1 Qualitative evaluation of leukocytes and protein to drive market
  • 10.6 MOLECULAR DIAGNOSTICS
    • 10.6.1 PCR TESTS
      • 10.6.1.1 Increasing laboratory usage in proteomics & genomics to fuel market
    • 10.6.2 MICROARRAYS
      • 10.6.2.1 Utilization of biochips in infectious disease diagnostics to support market
    • 10.6.3 OTHER MOLECULAR DIAGNOSTICS PRODUCTS
  • 10.7 OTHER TECHNOLOGIES

11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Rising pet healthcare expenditure to drive market
    • 11.2.3 CANADA
      • 11.2.3.1 Growing awareness of pet health to propel market
  • 11.3 EUROPE
    • 11.3.1 ECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Growing feline & canine population to drive market
    • 11.3.3 UK
      • 11.3.3.1 Stable increase in pet ownership and preventive measures against animal diseases to drive market
    • 11.3.4 FRANCE
      • 11.3.4.1 Technological expertise and innovative advancements in diagnostics to fuel uptake
    • 11.3.5 ITALY
      • 11.3.5.1 Increased pet adoption and enhanced availability of pet products to support market growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Rising animal health expenditure and growing number of veterinary facilities to drive market
    • 11.3.7 BENELUX
      • 11.3.7.1 Increasing pet population in Benelux to fuel uptake
    • 11.3.8 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Rising cases of zoonotic diseases to drive market
    • 11.4.3 JAPAN
      • 11.4.3.1 Increasing demand for imported pet breeds to drive market
    • 11.4.4 INDIA
      • 11.4.4.1 Growth in animal healthcare industry to drive market
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Growing focus on pet insurance to boost demand
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Growing focus on animal well-being to boost demand
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Growth in small animal population to support market
    • 11.5.3 MEXICO
      • 11.5.3.1 Increasing adoption of advanced diagnostic technologies to fuel uptake
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 RELUCTANCE TO SPEND ON PET HEALTH TO RESTRAIN MARKET
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES IN IMPORTED BREEDS TO SUPPORT MARKET GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Technology footprint
      • 12.5.5.4 Product footprint
      • 12.5.5.5 Animal type footprint
      • 12.5.5.6 Application footprint
      • 12.5.5.7 End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 R&D EXPENDITURE OF COMPANION ANIMAL DIAGNOSTICS COMPANIES
  • 12.10 COMPETITIVE SCENARIO
    • 12.10.1 PRODUCT LAUNCHES
    • 12.10.2 DEALS
    • 12.10.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 IDEXX
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 ZOETIS SERVICES LLC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches
        • 13.1.2.3.2 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 MARS, INCORPORATED
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 BIOMERIEUX
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 MnM view
        • 13.1.4.3.1 Key strengths
        • 13.1.4.3.2 Strategic choices
        • 13.1.4.3.3 Weaknesses & competitive threats
    • 13.1.5 FUJIFILM CORPORATION
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Key strengths
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 THERMO FISHER SCIENTIFIC INC.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
    • 13.1.7 NEOGEN CORPORATION
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
    • 13.1.8 VIRBAC
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
    • 13.1.9 BOULE
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
    • 13.1.10 INDICAL BIOSCIENCE GMBH
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 IDVET
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
    • 13.1.12 RANDOX LABORATORIES, LTD.
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
    • 13.1.13 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
    • 13.1.14 BIONOTE USA INC.
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product launches
        • 13.1.14.3.2 Deals
    • 13.1.15 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 SKYLA CORPORATION
    • 13.2.2 EUROLYSER DIAGNOSTICA GMBH
    • 13.2.3 NOVA BIOMEDICAL
    • 13.2.4 FASSISI GMBH
    • 13.2.5 SWISS BIOTECH ASSOCIATION
    • 13.2.6 ALVEDIA
    • 13.2.7 BIOPANDA REAGENTS LTD.
    • 13.2.8 MEGACOR VETERINARY DIAGNOSTICS
    • 13.2.9 URIT MEDICAL ELECTRONIC CO., LTD.
    • 13.2.10 RING BIOTECHNOLOGY CO., LTD.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 COMPANION ANIMAL DIAGNOSTICS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 COMPANION ANIMAL DIAGNOSTICS MARKET: IMPACT ANALYSIS
  • TABLE 4 COMPANION ANIMAL DIAGNOSTIC MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 5 COMPANION ANIMAL DIAGNOSTICS MARKET: IMPACT ANALYSIS
  • TABLE 6 PET POPULATION, DOGS VS. CATS, 2020-2022 (MILLION)
  • TABLE 7 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
  • TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012-2023 (USD MILLION)
  • TABLE 9 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
  • TABLE 10 COMMON ZOONOTIC DISEASES TRANSMITTED BY INFECTED COMPANION ANIMALS
  • TABLE 11 POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
  • TABLE 12 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION)
  • TABLE 13 EXPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 14 IMPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 15 AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTICS, BY KEY PLAYER (2023)
  • TABLE 16 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION, 2021-2023 (USD)
  • TABLE 17 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
  • TABLE 23 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • TABLE 24 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 25 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 COMPANION ANIMAL DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 28 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 34 DOG POPULATION, BY COUNTRY, 2022-2024 (MILLION)
  • TABLE 35 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 CAT POPULATION, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 37 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 HORSE POPULATION, 2020-2022
  • TABLE 39 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 OTHER COMPANION ANIMALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 42 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2024) (USD)
  • TABLE 44 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 48 LIST OF KEY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE
  • TABLE 49 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 LIST OF KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE
  • TABLE 52 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 53 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 57 LIST OF KEY GLUCOSE MONITORING PRODUCTS AVAILABLE
  • TABLE 58 GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 59 GLUCOSE MONITORING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 GLUCOSE MONITORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 GLUCOSE MONITORS MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
  • TABLE 63 LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE
  • TABLE 64 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 66 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 BLOOD GAS ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
  • TABLE 70 LIST OF KEY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE
  • TABLE 71 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 72 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 74 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES
  • TABLE 76 LIST OF KEY LATERAL TEST KITS AVAILABLE
  • TABLE 77 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 ELISA: ADVANTAGES & DISADVANTAGES
  • TABLE 80 LIST OF KEY ELISA TEST KITS AVAILABLE
  • TABLE 81 ELISA TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 ELISA TESTS MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 83 LIST OF KEY ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC KITS AVAILABLE
  • TABLE 84 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
  • TABLE 86 LIST OF KEY IMMUNOASSAY ANALYZERS AVAILABLE
  • TABLE 87 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
  • TABLE 89 LIST OF KEY IMMUNOASSAY REAGENTS & CONSUMABLES AVAILABLE
  • TABLE 90 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 LIST OF KEY HEMATOLOGY PRODUCTS AVAILABLE
  • TABLE 92 HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 93 HEMATOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (THOUSAND UNITS)
  • TABLE 97 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE
  • TABLE 98 URINALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 99 URINALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 LIST OF KEY CLIPS & CARTRIDGES AVAILABLE
  • TABLE 101 URINALYSIS CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 URINE ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 URINE ANALYZERS MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 104 URINE TEST STRIPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 106 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 LIST OF KEY PCR TESTS AVAILABLE
  • TABLE 108 PCR TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 PCR TESTS MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 110 LIST OF KEY MICROARRAY TESTS AVAILABLE
  • TABLE 111 MICROARRAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 MICROARRAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 OTHER MOLECULAR DIAGNOSTICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 131 US: KEY MACROINDICATORS
  • TABLE 132 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 133 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 134 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 135 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 136 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 138 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 139 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 140 US: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 141 US: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 142 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 143 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 145 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 146 CANADA: KEY MACROINDICATORS
  • TABLE 147 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 148 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 149 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 150 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 151 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 153 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 154 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 155 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 156 CANADA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 157 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 158 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 160 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 161 EUROPE: COMPANION ANIMAL POPULATION, 2022 (MILLION)
  • TABLE 162 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 165 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 166 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 169 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 170 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 172 EUROPE: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 173 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 174 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 176 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 177 GERMANY: KEY MACROINDICATORS
  • TABLE 178 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 179 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 180 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 181 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 182 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 184 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 186 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 187 GERMANY: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 188 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 189 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 191 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 192 UK: HOUSEHOLDS WITH PETS (2022)
  • TABLE 193 UK: KEY MACROINDICATORS
  • TABLE 194 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 195 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 196 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 197 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 198 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 200 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 201 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 202 UK: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 203 UK: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 204 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 205 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 207 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 208 FRANCE: KEY MACROINDICATORS
  • TABLE 209 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 210 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 211 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 212 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 213 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 215 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 216 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 217 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 218 FRANCE: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 219 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 220 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 222 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 223 ITALY: KEY MACROINDICATORS
  • TABLE 224 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 225 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 226 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 227 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 228 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 230 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 231 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 232 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 233 ITALY: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 234 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 235 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 237 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 238 SPAIN: KEY MACROINDICATORS
  • TABLE 239 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 240 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 241 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 242 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 243 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 245 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 246 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 247 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 248 SPAIN: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 249 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 250 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 252 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 253 BENELUX: KEY MACROINDICATORS
  • TABLE 254 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 255 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 256 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 257 BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 258 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 260 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 261 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 262 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 263 BENELUX: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 264 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 265 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 267 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 269 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 272 REST OF EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 274 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 275 REST OF EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 276 REST OF EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 277 REST OF EUROPE: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 278 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 279 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 281 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 283 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 284 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 286 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 287 ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 291 ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 297 CHINA: KEY MACROINDICATORS
  • TABLE 298 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 299 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 300 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 301 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 302 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 303 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 304 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 305 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 306 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 307 CHINA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 308 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 309 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 311 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 312 JAPAN: KEY MACROINDICATORS
  • TABLE 313 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 314 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 315 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 316 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 317 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 319 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 320 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 321 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 322 JAPAN: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 323 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 324 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 326 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 327 INDIA: KEY MACROINDICATORS
  • TABLE 328 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 329 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 330 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 331 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 332 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 333 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 334 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 335 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 336 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 337 INDIA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 338 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 339 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 340 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,2022-2029 (USD MILLION)
  • TABLE 341 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 342 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 343 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 344 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 345 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 346 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 347 AUSTRALIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 348 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 349 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 350 AUSTRALIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 351 AUSTRALIA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 352 AUSTRALIA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 353 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 354 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 355 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 356 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 357 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 358 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 359 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 360 SOUTH KOREA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 361 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 362 SOUTH KOREA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 364 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 365 SOUTH KOREA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 366 SOUTH KOREA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 367 SOUTH KOREA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 368 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 369 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 371 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 372 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 373 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 374 REST OF ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 375 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 376 REST OF ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 377 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 378 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 379 REST OF ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 380 REST OF ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 386 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 387 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 388 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 390 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 391 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 392 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 393 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 395 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 401 BRAZIL: KEY MACROINDICATORS
  • TABLE 402 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 403 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 404 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 405 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 406 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 407 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 408 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 409 BRAZIL: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 410 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 411 BRAZIL: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 412 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 413 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 414 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 415 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 416 MEXICO: KEY MACROINDICATORS
  • TABLE 417 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 418 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 419 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 420 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 421 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 422 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 423 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 424 MEXICO: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 425 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 426 MEXICO: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 427 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 428 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 429 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 430 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 431 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 432 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 433 REST OF LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 434 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 435 REST OF LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 436 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 437 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 438 REST OF LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 439 REST OF LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 440 REST OF LATIN AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 441 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 442 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 443 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 444 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 445 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 446 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 447 MIDDLE EAST & AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 448 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 449 MIDDLE EAST & AFRICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 450 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 451 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 452 MIDDLE EAST & AFRICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 453 MIDDLE EAST & AFRICA: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 454 MIDDLE EAST & AFRICA: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 455 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 456 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 457 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 458 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 459 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 460 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 461 GCC COUNTRIES: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 462 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 463 GCC COUNTRIES: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 464 GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 465 GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 466 GCC COUNTRIES: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 467 GCC COUNTRIES: HEMATOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 468 GCC COUNTRIES: URINANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 469 GCC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 470 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 471 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 472 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 473 COMPANION ANIMAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 474 COMPANION ANIMAL DIAGNOSTICS MARKET: REGION FOOTPRINT
  • TABLE 475 COMPANION ANIMAL DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 476 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
  • TABLE 477 COMPANION ANIMAL DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 478 COMPANION ANIMAL DIAGNOSTICS MARKET: APPLICATION FOOTPRINT
  • TABLE 479 COMPANION ANIMAL DIAGNOSTICS MARKET: END-USER FOOTPRINT
  • TABLE 480 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS
  • TABLE 481 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 482 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES (JANUARY 2021-NOVEMBER 2024)
  • TABLE 483 COMPANION ANIMAL DIAGNOSTICS MARKET: DEALS (JANUARY 2021- NOVEMBER 2024)
  • TABLE 484 COMPANION ANIMAL DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2021- NOVEMBER 2024
  • TABLE 485 IDEXX: COMPANY OVERVIEW
  • TABLE 486 IDEXX: PRODUCTS OFFERED
  • TABLE 487 IDEXX: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 488 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 489 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 490 ZOETIS SERVICES LLC: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 491 ZOETIS SERVICES LLC.: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 492 MARS, INCORPORATED: COMPANY OVERVIEW
  • TABLE 493 MARS, INCORPORATED: PRODUCTS OFFERED
  • TABLE 494 MARS, INCORPORATED: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 495 MARS, INCORPORATED: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 496 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 497 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 498 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 499 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 500 FUJIFILM CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 501 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 502 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
  • TABLE 503 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 504 NEOGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 505 NEOGEN CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 506 VIRBAC: COMPANY OVERVIEW
  • TABLE 507 VIRBAC: PRODUCTS OFFERED
  • TABLE 508 BOULE: COMPANY OVERVIEW
  • TABLE 509 BOULE: PRODUCTS OFFERED
  • TABLE 510 BOULE: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 511 BOULE: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 512 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 513 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
  • TABLE 514 IDVET: COMPANY OVERVIEW
  • TABLE 515 IDVET: PRODUCTS OFFERED
  • TABLE 516 RANDOX LABORATORIES, LTD.: COMPANY OVERVIEW
  • TABLE 517 RANDOX LABORATORIES, LTD.: PRODUCTS OFFERED
  • TABLE 518 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 519 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 520 BIONOTE USA INC.: COMPANY OVERVIEW
  • TABLE 521 BIONOTE USA INC: PRODUCTS OFFERED
  • TABLE 522 BIONOTE USA INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 523 BIONOTE USA INC.: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 524 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
  • TABLE 525 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 COMPANION ANIMAL DIAGNOSTICS MARKET: MARKETS COVERED & REGIONS CONSIDERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 8 SUPPLY SIDE ANALYSIS OF LEADING COMPANIES (2023)
  • FIGURE 9 CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2024-2029)
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 19 GROWING COMPANION ANIMAL POPULATION TO PROPEL MARKET
  • FIGURE 20 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 CLINICAL CHEMISTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA IN 2023
  • FIGURE 22 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION (2021-2023)
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 PATENT PUBLICATION TRENDS (2014-APRIL 2024)
  • FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • FIGURE 35 VETERINARY DIAGNOSTICS MARKET OVERVIEW
  • FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
  • FIGURE 37 IMPACT OF AI/GEN AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 38 NUMBER OF DEALS & FUNDS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2018-2022 (USD MILLION)
  • FIGURE 39 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022
  • FIGURE 40 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 41 CORNELL UNIVERSITY: SPONSORED RESEARCH & DIRECT COST EXPENSES BETWEEN FY 2019-FY 2023 (USD MILLION)
  • FIGURE 42 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 44 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PRODUCT COMPANIES
  • FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET (2019-2023)
  • FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET (2023)
  • FIGURE 47 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 48 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 49 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 52 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023)
  • FIGURE 54 IDEXX: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2023)
  • FIGURE 56 BIOMERIEUX: COMPANY SNAPSHOT (2023)
  • FIGURE 57 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2024)
  • FIGURE 61 BOULE: COMPANY SNAPSHOT (2023)